Endologix Appoints Graham Phillips as Chief Operating Officer

June 18, 2024—Endologix LLC announced the appointment of Graham Phillips as Chief Operating Officer, effective immediately.

In his new role, Phillips will oversee manufacturing, supply chain, research and development, and quality and will be a member of the executive leadership team, reporting directly to Matt Thompson, MD, Endologix President and CEO.

“I am delighted to welcome Graham to Endologix,” commented Dr. Thompson in the company’s press release. “His proven leadership and extensive operational expertise will be invaluable as we continue to drive growth and innovation within our company.”

According to the company, Phillips joins Endologix after 18 years at Medtronic, Covidien, and Tyco Healthcare, where most recently he served as Vice President of Manufacturing for the Americas East Region. In this role, he led a large global team across 25 manufacturing sites, including Canada, Brazil, the Caribbean, and the United States Midwest and East Coast. Before his career in medical devices, Phillips held key manufacturing management positions at Budelpack (a third-party European contract manufacturer) and Kraft Foods.

Phillips earned a bachelor’s degree in mechanical engineering from University of Teesside in Middlesbrough, United Kingdom; an MBA from University of Warwick Business School in Coventry, United Kingdom; and an Advanced Management qualification from Chicago Booth Business School in Chicago, Illinois. Additionally, he is a Chartered Engineer with the United Kingdom’s Institute of Mechanical Engineers and holds a Six Sigma Black Belt.

“Joining Endologix represents a remarkable opportunity to leverage my extensive background in operational management to put patients first through innovation and enhancing our manufacturing and R&D processes,” stated Phillips in the press release. “My commitment is to optimize our operational capabilities to support Endologix’s mission of delivering health care innovation to improve the lives of patients with vascular disease.”